Invited Lectures PDF Print E-mail
    • 11TH Annual Frontiers in Endourology, St. Louis, MO, June 1997
           Instructor in laboratory session
  • 12TH Annual Frontiers in Endourology, St. Louis, MO, June 1998
         Instructor in laboratory session
  • American College of Radiology Imaging Network, Washington, D.C., October 1999
         “Clinical Perspectives on Prostate Cancer”
  • Department of Urology, grand rounds, George Washington University, November 1999
         “Prostate Cancer Update”
  • Division of Clinical Sciences Fellows Symposium 2000, NIH, March 2000
         “Dysregulation of Annexin I Protein Expression In Human Esophageal and Prostatic Carcinoma.” Abstract was chosen  for 1 of 2 oral presentations.
  • The Management of Prostate Cancer: Certainties and Controversies in the Year 2000, Philadelphia, PA April 2000
         “Strategies for Biochemical Recurrence After Surgery or Radiation Therapy
  • Department of Surgery, grand rounds, Holy Cross Hospital, Silver Spring, MD, May 2000
         “Prostate Cancer Update”
  • AHEC Lecture, Nash General Hospital, September 2000
         “Prostate Cancer: When to Screen, Whom to Treat”
  • Department of Surgery Grand Rounds, UNC, August 2000
         “Prostate Cancer Update”
  • Laparoscopic renal surgery, course co-director, UNC, June 2001
  • Laparoscopic renal surgery, course co-director, UNC, September 2001
  • Dysregulation of annexin I protein expression in high grade prostatic intraepithelial neoplasia and prostate cancer.
         Poster presentation at 8th annual CaPCURE retreat, September 2001.
  • Division of Urology Prostate Cancer Research Conference, The University of Wisconsin, November 2001
         “Proteomic Studies of Prostate Cancer: New Opportunities for Discovery and Novel Clinical Applications.”
  • Womack Medical Facility, May 2002
         “Prostate Cancer Update”
  • AHEC Lecture, Randolph Hospital, June 2002
         “Prostate Cancer Screening and Treatment in the PSA-ERA”
  • Department of Urology Grand Rounds, The University of California at Irvine, June 2002
         “Proteomic Studies of Prostate Cancer: New Opportunities for Discovery and Novel Clinical Applications.”
  • Fayetteville North Carolina, June 2002
         “Kidney Cancer Update”
  • Urology Grand Rounds, Yale University, October 2002
         “Proteomic Studies of Prostate Cancer: New Opportunities for Discovery and Novel Clinical Applications.”
  • Third Annual Urologic Oncology: Extraordinary Opportunities for Discovery, Bethesda, MD December 2002
         “PSA and Prostate Cancer Proteomics”
  • Multidisciplinary Advances In The Treatment of Prostate Cancer, Chapel Hill, NC, January 2003
         “New Technology for Detection of Prostate Cancer” and moderator for panel discussion on detection and staging
  • Southeastern Section of the AUA, 67th annual meeting, Savannah, GA, March 2003 Moderator kidney podium session
  • Forth Annual Urologic Oncology: Extraordinary Opportunities for Discovery, Bethesda, MD December 2003
         Moderator for Young Urologist Session
  • New Frontiers in Endourology, UCIMC, March 2004
         Course faculty
  • The UCI Family Medicine Update Course, June 2004
         Prostate Cancer
  • Northwestern University SPORE Meeting, June 2004
         “The Role of Annexin I Down-Regulation in Prostate Cancer Development”
  • Stanford University Department of Urology Basic Science Seminar, July 2004
         “Proteomic Studies of Human Prostate Cancer”
  • Western Section of the AUA, 80th Annual Meeting, San Diego, CA, August 2004 PREP C course,
         “Prostate Cancer, Penis and Urethra”
  • Visiting Professor, Roswell Park Cancer Institute, Buffalo, NY, September 2004
  • Medical Center Grand Rounds, Lakewood Medical Center, Lakewood, CA
         “Prostate Cancer Update” April 2005
  • Nephrology Grand Rounds, UCIMC, Orange, CA
         “Renal Cell Carcinoma” May 2005
  • Society of Urologic Oncology Spring Meeting, San Antonio, TX
         “Proteomics, New Serum Markers in Prostate Cancer” May 2005
  • AUA Postgraduate Course, Laparoscopic and Robotic Surgery in Urologic Oncology, San Antonio, TX
         “Robotic-Assisted Laparoscopic Transperitoneal Radical Prostatectomy” May 2005
  • New Frontiers in Endourology, UCIMC, March 2005
         Course faculty
  • The UCI Family Medicine Update Course, June 2005
         “Prostate Cancer Update”
  • The Third Annual Louisiana Statewide Prostate Cancer Symposium, New Orleans, LA, August 2005
         “What’s New in the Diagnosis and Treatment of Prostate Cancer: From Genomics to Robotics”
  • American Association for Clinical Chemistry, Southern California Section Meeting, Los Angeles CA, September 2005
         “Diagnosis and Management of Prostate Cancer in the Early 21st Century: From PSA to    Robotics”
  • Advanced Robotic Techniques Symposium, Anaheim, CA, January 2006
         “Techniques of Robotic Prostatectomy - Basic Concepts
  • Colegio Mexicano de Urologia, Sonora, Mexico,March 2006
         “Robotic Surgery in Urologic Ocology”
  • The UCI Family Medicine Update Course, June 2006
         “Prostate Cancer Update "
  • Encino-Tarzana Regional Medical Center’s CME Program, Tarzana, CA, September 2006
         “Prostate Cancer Update”
  • German Urological Association, Hamburg, Germany, September 2006
         “Can molecular techniques make prostate biopsies redundant? ”
  • Advance Robotic Techniques Symposium, May 2007                                                                         "Complications"  "Learning Curve"  Live case demonstration of robotic radical prostatectomy
  • 25th World Congress of Endourology & SWL 2007, Cancun Mexico                                                            "Update on Radical Cystectomy" November 2007
 
Next >
Whats New
Orange County Physician of Excellence
Dr. Ornstein was recently selected as an Orange County Physician of Excellence by the Orange County Medical Association.
 
Vanguard Urologic Institute
Dr. Ornstein recently relocated to Houston to join the Vanguard Urologic Institute in the Texas Medical Center where he will be Director of Urologic Oncology and Medicial Director of the Vanguard Urologic Research Foundation. Dr. Ornstein will continue to apply his vast experience and expertise in robotic surgery to treat patients with prostate, bladder and kidney cancer.
 
Experienced Robotic Surgeon

Dr. Ornstein has successfully completed nearly 500 robotic surgeries including more than 400 robotic prostatectomies for prostate cancer and more than 65 robotic cystectomies for bladder cancer. 
 
The Best Doctors in America
Dr. Ornstein was named as one of "The Best Doctors in America" for the second year in a row.
 
Dr. Ornstein wins award

At the 2007 annual meeting of the American Urologic Association, Dr. Ornstein became the 6th recipient of the prestigious Investigator Award from the Society of Urologic Oncology. This award recognizes excellence in both research and clinical practice in the area of urologic oncology.

 
Affiliations










© 2009 DavidOrnsteinMD